PP_1170x120_10-25-21

Schizophrenia

Aurobindo gets FDA approval for aripiprazole oral solution

Aurobindo gets FDA approval for aripiprazole oral solution

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for aripiprazole oral solution, 1 mg/mL. Aurobindo’s aripiprazole oral solution is an AB-rated generic equivalent to the reference listed drug, Otsuka’s Abilify Oral Solution. Aripiprazole oral solution is indicated for the treatment of: Schizophrenia